-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNITYBIO ANNOUNCES FIRST PATIENTS IN EUROPE TREATED WITH ANKTIVA® PLUS BCG FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU

Reuters·11/04/2026 13:00:05

Please log in to view news